SCHEMBL25112581

SCHEMBL25112581

N#Cc1ccc(-c2cccc(-c3nc(-c4cccc(-c5ccccc5)c4)nc(-c4cc5ccc6cccc7c8cccc9ccc%10cccc(c(c4)c5c67)c%10c98)n3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 8/20 0.41
CYP3A4 P08684 6/20 0.41
MEN1 O00255 4/20 0.41
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 4/20 0.41
LMNA P02545 4/20 0.41
CYP2D6 P10635 4/20 0.41
CYP2C19 P33261 3/20 0.41
CLK4 Q9HAZ1 3/20 0.41
HSD17B10 Q99714 3/20 0.41
TSHR P16473 3/20 0.41
MAPK1 P28482 2/20 0.41
CYP2C9 P11712 2/20 0.41
ABCG2 Q9UNQ0 8/20 0.40
ABCB1 P08183 3/20 0.40
TP53 P04637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25112583 0.99 CYP1A2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL25112582 0.99 CYP1A2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL25112662 0.96 CYP1A2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL25112571 0.96 CYP1A2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL25112687 0.96 CYP1A2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL25112686 0.96 CYP1A2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL25112660 0.95 ABCG2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL25112685 0.95 CYP1A2 (0.44) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL25112665 0.95 ABCG2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL25112568 0.93 ABCG2 (0.45) CYP1A2CYP3A4MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, PIEZO1, LEF1 CYP1A2 1265/4885CYP3A4 2369/4885MEN1 205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.